Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | f10k123117_ex31z2.htm |
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | f10k123117_ex31z1.htm |
10-K - FORM 10-K ANNUAL REPORT - THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | f10k123117_10k.htm |
Exhibit 32.1
SARBANES-OXLEY SECTION 906 CERTIFICATION
In connection with the Annual Report on Form 10-K of Therapeutic Solutions International, Inc. (the "Company") for the year ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Dixon, Chief Executive Officer and President of the Company, and I, Gerry Berg, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 17, 2018
By: /s/ Timothy G. Dixon
Timothy G. Dixon
Chief Executive Officer and President
(Principal Executive Officer)
By: /s/ Gerry Berg
Gerry Berg
Chief Financial Officer (Principal Financial Officer)